RT3 + Tesamorelin Duo
RT3-GLP
Tesamorelin
The Retatrutide + Tesamorelin Duo is studied for its synergistic effects on metabolism, energy regulation, and recovery. Together they provide a research model for exploring how incretin and growth hormone pathways interact to support fat reduction, lean mass maintenance, and metabolic resilience.
Description
The Retatrutide + Tesamorelin Duo combines two advanced metabolic peptides studied for their complementary roles in energy regulation, fat metabolism, and cellular repair. This pairing is designed for research exploring how incretin receptor activation and growth hormone (GH) release work together to influence body composition, insulin sensitivity, and metabolic recovery.
Research Focus
-
Combined effects on lipid metabolism, energy expenditure, and insulin regulation.
-
Interaction between triple incretin receptor activation (GLP-1, GIP, glucagon) and GHRH receptor signaling.
-
Study of fat reduction and lean mass preservation in metabolic adaptation models.
-
Exploration of hormonal coordination in nutrient sensing, mitochondrial function, and recovery.
-
Investigation of metabolic balance following stress, caloric restriction, or age-related decline.
Why They’re Paired
Retatrutide acts on multiple incretin pathways to optimize glucose and lipid metabolism, while Tesamorelin stimulates endogenous GH and IGF-1 release to support cellular repair and lean tissue preservation. Together, they represent a dual-pathway approach to studying metabolic enhancement where Retatrutide drives energy balance and Tesamorelin promotes regeneration and recovery.
Product Information
-
Supplied as two lyophilized sterile powders for controlled laboratory research.
-
Third-party verified for purity, molecular identity, and composition.
-
For laboratory research use only; not for human or animal use.
